Vesalius BioCapital is an established life sciences venture capital firm with a long track record of consistent returns. Their seasoned team of domain experts invest in best/first-in-class European Biopharma and HealthTech companies. The fund is fully ESG compliant.
This MasterClass, to be presented by Stéphane Verdood of Vesalius Biocapital on the 27th of June will focus on “Investing in Venture Capital”.